Inactive Instrument

Official Publications Cardionet Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 01	Ayala Pharmaceuticals, Inc. announced that it has received $2 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	CI
2023	Ayala Pharmaceuticals, Inc. entered into a definitive merger agreement to acquire BioSight Ltd from Israel Biotech Fund, BioTelemetry, Inc., Arkin Bio Venture Partners Ltd., Primera Capital, SBI JI Innovation Advisory Ltd., Migdal Insurance Company Ltd., The Phoenix Insurance Company Ltd. and others.	CI

No official publication found